Targeting the Downstream Mechanisms of Autoimmune Damage
While current therapies for Membranous Nephropathy (MN) primarily focus on eliminating the B-cells that produce the initial antibodies (like anti-PLA2R), a promising new class of drugs is focused on neutralizing the damage mechanism itself: the complement cascade. The complement system is a crucial part of the innate immune response, but...
Turkish 
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt